Literature DB >> 18346672

Insomnia and comorbid psychiatric disorders.

Dieter Riemann1.   

Abstract

Defining the relationship between sleep disturbances and psychiatric disorders is a thought-provoking task and is becoming even more challenging because it is apparent that insomnia is not simply a typical symptom of a psychiatric disorder but may actually be a predictor (or independent risk factor) for the development of such a condition. Studies have shown that depressed patients not only have disturbances in sleep continuity but have reduced slow wave sleep and disinhibited REM sleep. In particular, REM sleep regulation is characterized by shortened REM latency and increased REM density. It has been suggested that the reciprocal interaction between REM and nonREM sleep, driven by inhibitory aminergic and excitatory cholinergic activity, becomes unbalanced in depression. Exposure to cholinergic stimulants reduces REM latency, particularly in major depressive disorder. In fact, it has been shown that healthy individuals at high risk for developing depression have greater sensitivity to cholinergic stimulation than those not at high risk. While the causality of the insomnia-depression relationship is debated, epidemiological studies have indicated that insomnia is an independent risk factor for depression and other psychiatric disorders. As we learn more about the interplay between these pathophysiologies, we will be able to make better treatment decisions for our patients.

Entities:  

Mesh:

Year:  2007        PMID: 18346672     DOI: 10.1016/S1389-9457(08)70004-2

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  47 in total

1.  Sleep physiology, abnormal States, and therapeutic interventions.

Authors:  Alvah T Wickboldt; Alex F Bowen; Aaron J Kaye; Adam M Kaye; Franklin Rivera Bueno; Alan D Kaye
Journal:  Ochsner J       Date:  2012

2.  Mood and Anxiety Symptoms in Psychiatric Inpatients with Autism Spectrum Disorder and Depression.

Authors:  Lauren Charlot; Curtis K Deutsch; Aranya Albert; Anne Hunt; Daniel F Connor; William J McIlvane
Journal:  J Ment Health Res Intellect Disabil       Date:  2008

Review 3.  A critical review of human endotoxin administration as an experimental paradigm of depression.

Authors:  Nicole DellaGioia; Jonas Hannestad
Journal:  Neurosci Biobehav Rev       Date:  2009-08-08       Impact factor: 8.989

4.  Insomnia and attention deficit hyperactivity disorder in pediatrics: a checklist for parents.

Authors:  Atmaram Yarlagadda; Megan A Connell; Jayaprada Kasaraneni; Anita H Clayton
Journal:  Innov Clin Neurosci       Date:  2013-11

5.  Resting state functional connectivity in primary insomnia, generalized anxiety disorder and controls.

Authors:  Edward F Pace-Schott; Jared P Zimmerman; Ryan M Bottary; Erik G Lee; Mohammed R Milad; Joan A Camprodon
Journal:  Psychiatry Res Neuroimaging       Date:  2017-05-08       Impact factor: 2.376

6.  Processing of emotional reactivity and emotional memory over sleep.

Authors:  Bengi Baran; Edward F Pace-Schott; Callie Ericson; Rebecca M C Spencer
Journal:  J Neurosci       Date:  2012-01-18       Impact factor: 6.167

7.  A randomized controlled trial of an internet intervention for adults with insomnia: effects on comorbid psychological and fatigue symptoms.

Authors:  Frances P Thorndike; Lee M Ritterband; Linda A Gonder-Frederick; Holly R Lord; Karen S Ingersoll; Charles M Morin
Journal:  J Clin Psychol       Date:  2013-08-28

8.  Telehealth cognitive behavior therapy for co-occurring insomnia and depression symptoms in older adults.

Authors:  Kenneth L Lichstein; Forrest Scogin; S Justin Thomas; Elizabeth A DiNapoli; Haley R Dillon; Anna McFadden
Journal:  J Clin Psychol       Date:  2013-08-22

9.  Risk of psychiatric disorders in patients with chronic insomnia and sedative-hypnotic prescription: a nationwide population-based follow-up study.

Authors:  Kuo-Hsuan Chung; Chung-Yi Li; Shu-Yu Kuo; Trevor Sithole; Wen-Wei Liu; Min-Huey Chung
Journal:  J Clin Sleep Med       Date:  2015-04-15       Impact factor: 4.062

10.  Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management.

Authors:  Magdolna Hornyak
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.